Viatris

Pharmaceuticals
VTRS
$ 12 0.46
Share price
$ 14 bn
Market Cap
$ 34 bn
Enterprise Value

Carbon footprint

23 Ton
GHG emissions per $ 1 mln investment
0.61x the weighted average for S&P 500
FY2021
How is this calculated?
-1.8%
YOY change in GHG emissions
Weaker than the +4.5% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

but has a science based goal that does not target absolute reductions but is still aligned with Paris Agreement according to SBTi

GHG emissions and Carbon intensity

Viatris's GHG emissions (market-based) (Kt of CO2e)
Viatris's Carbon intensity (Tons per 1 USDm)

Viatris's carbon footprint

Viatris reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 771 Kt (-14 /-1.8% y-o-y). Also positively, carbon intensity tumbled to 43 t (-23 /-34.4% y-o-y).

No public disclosure of Scope 3 emissions has been found for Viatris at the moment.

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Viatris also has a science-based goal that, however, does not appear to explicitly target a company-wide reduction in emissions in absolute terms. Viatris Inc. commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2020 base year.* Viatris Inc. also commits to reduce absolute scope 3 GHG emissions covering purchased goods and services, capital goods, fuel and energy related activities, and upstream transportation and distribution 25% within the same timeframe. * The target boundary includes land-related emissions and removals from bioenergy feedstocks.

Company environmental metrics

Show more...